Autres langues Ajinomoto Co., Inc.

Actions

2802

JP3119600009

Temps Différé Japan Exchange Autres places de cotation 08:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
5 775 ^JPY	+1,57%		+7,50%	+6,16%

27/03	Transcript : Ajinomoto Co., Inc. - Analyst/Investor Day
26/03	Ajinomoto Co. améliore le milieu d'expansion des cellules iPS StemFit	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Ajinomoto : Enhancing Corporate Value through ASV Management	27/03
Ajinomoto : Sustainability Initiatives Aimed at Enhancement of Corporate Value	27/03
TechMagic, Inc. announced that it has received funding from a group of investors	27/03
Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium	26/03
Ajinomoto (Malaysia) Closes MYR408 Million Sale of Six Kuala Lumpur Land Plots	12/03
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on November 13, 2023.	08/03
Ajinomoto Co., Inc.'s Equity Buyback announced on November 13, 2023, has closed with 7,003,300 shares, representing 1.35% for ¥39,999.85 million.	07/03
Tsubame BHB Co., Ltd. announced that it has received ¥5.3 billion in funding from a group of investors	21/02
Ajinomoto Foods Restates Commitment to Quality Products	15/02
Inglewood Co., Ltd. announced that it has received funding from Ajinomoto Co., Inc.	31/01
Ribomic and Ajinomoto Co. Partner for Nucleic Acid Aptamer Research	17/01
Ribomic Enters Into Drug Research Collaboration with Ajinomoto	17/01
RIBOMIC Inc. and Ajinomoto Co., Inc. Announce Joint Research Agreement	16/01
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on November 13, 2023.	05/01
New acquisition to support global gene therapy manufacturing	14/11
Forge Biologics - Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1	14/11
Ajinomoto Co., Inc. übernimmt Forge Biologics für 620 Millionen Dollar1	13/11
Japan's Ajinomoto to buy US-based Forge Biologics for $546 million	13/11
Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1	13/11
Ajinomoto Co., Inc. announces an Equity Buyback for 10,000,000 shares, representing 1.92% for ¥40,000 million.	13/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Ajinomoto Co., Inc.

Actions

2802

JP3119600009

Autres langues

Filtres